BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22776235)

  • 41. A cross-standardized flow cytometry platform to assess phenotypic stability in precursor B-cell acute lymphoblastic leukemia (B-ALL) xenografts.
    Rolf N; Liu LYT; Tsang A; Lange PF; Lim CJ; Maxwell CA; Vercauteren SM; Reid GSD
    Cytometry A; 2022 Jan; 101(1):57-71. PubMed ID: 34128309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Analysis of Immunophenotypes in 329 Patients with B-ALL at Different Ages].
    Zheng YH; Lin YF; Xu RY; Zhou YZ; Huang YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1225-30. PubMed ID: 26524013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunophenotyping of acute lymphoblastic leukemia in pediatric patients by three-color flow cytometric analysis.
    Tiensiwakul P; Lertlum T; Nuchprayoon I; Seksarn P
    Asian Pac J Allergy Immunol; 1999 Mar; 17(1):17-21. PubMed ID: 10403005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hematogones as an internal control in flow cytometric analysis of suspected acute lymphoblastic leukemia.
    Vargas SO; Hasegawa SL; Dorfman DM
    Pediatr Dev Pathol; 1999; 2(4):371-6. PubMed ID: 10347282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute leukemias of ambiguous origin.
    Porwit A; Béné MC
    Am J Clin Pathol; 2015 Sep; 144(3):361-76. PubMed ID: 26276768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.
    le Viseur C; Hotfilder M; Bomken S; Wilson K; Röttgers S; Schrauder A; Rosemann A; Irving J; Stam RW; Shultz LD; Harbott J; Jürgens H; Schrappe M; Pieters R; Vormoor J
    Cancer Cell; 2008 Jul; 14(1):47-58. PubMed ID: 18598943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
    Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early recovery of circulating immature B cells in B-lymphoblastic leukemia patients after CD19 targeted CAR T cell therapy: A pitfall for minimal residual disease detection.
    Xiao W; Salem D; McCoy CS; Lee D; Shah NN; Stetler-Stevenson M; Yuan CM
    Cytometry B Clin Cytom; 2018 May; 94(3):434-443. PubMed ID: 28888074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flow cytometry immunophenotyping evaluation in acute lymphoblastic leukemia: correlation to factors affecting clinic outcome.
    Alves GV; Fernandes AL; Freire JM; Paiva Ade S; Vasconcelos RC; Sales VS; Lemos TM; Gil EA; Freire FH; Cavalcanti e Silva DG; Maciel JF; Farkatt IG; Cavalcanti Júnior GB
    J Clin Lab Anal; 2012 Nov; 26(6):431-40. PubMed ID: 23143625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.
    Raponi S; De Propris MS; Intoppa S; Milani ML; Vitale A; Elia L; Perbellini O; Pizzolo G; Foá R; Guarini A
    Leuk Lymphoma; 2011 Jun; 52(6):1098-107. PubMed ID: 21348573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adult precursor-B acute lymphoblastic leukemia with translocations involving chromosome band 19p13 is associated with poor prognosis.
    Khalidi HS; O'Donnell MR; Slovak ML; Arber DA
    Cancer Genet Cytogenet; 1999 Feb; 109(1):58-65. PubMed ID: 9973961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma.
    Pilozzi E; Pulford K; Jones M; Müller-Hermelink HK; Falini B; Ralfkiaer E; Pileri S; Pezzella F; De Wolf-Peeters C; Arber D; Stein H; Mason D; Gatter K
    J Pathol; 1998 Oct; 186(2):140-3. PubMed ID: 9924428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Precursor B lymphoblastic leukemia with surface light chain immunoglobulin restriction: a report of 15 patients.
    Kansal R; Deeb G; Barcos M; Wetzler M; Brecher ML; Block AW; Stewart CC
    Am J Clin Pathol; 2004 Apr; 121(4):512-25. PubMed ID: 15080303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD19-negative B-lineage acute lymphoblastic leukemia: A diagnostic and therapeutic challenge.
    Bansal S; Sharma U; Jain A; Sharma R; Yagnik B
    Indian J Pathol Microbiol; 2017; 60(4):596-598. PubMed ID: 29323085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunophenotypic analysis of Philadelphia chromosome positive acute lymphoblastic leukaemia in adults].
    Chen HY; Ge Z; Wu YJ; Wu LY; Sun M; Tian T; Qiou HR; Liu P; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):714-7. PubMed ID: 20561435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Demonstration of functional CD40 in B-lineage acute lymphoblastic leukemia cells in response to T-cell CD40 ligand.
    Renard N; Lafage-Pochitaloff M; Durand I; Duvert V; Coignet L; Banchereau J; Saeland S
    Blood; 1996 Jun; 87(12):5162-70. PubMed ID: 8652829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunologic variants of acute lymphoblastic leukemia in adults and its correlation with cytochemical and various clinical parameters].
    Bulycheva TI; Novikova MS; Miterev GIu; Shakhbazian GP; Novikova NN
    Gematol Transfuziol; 1989 May; 34(5):13-9. PubMed ID: 2787263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunobiologic differences between normal and leukemic human B-cell precursors.
    Uckun FM; Ledbetter JA
    Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8603-7. PubMed ID: 2460871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparison of the immunophenotype of patients with B lineage acute lymphoblastic leukemia at diagnosis and relapse].
    Liu YR; Chang Y; Fu JY; Cheng YF; Zhang LP; Li LD; Wang H; Liu GL; Chen SS; Huang XJ; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):335-8. PubMed ID: 16875586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
    Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF
    Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.